Gelissen, Liza M. Y.
van den Bergh, Robin
Talebi, Amir H.
Geerlings, Angelika D.
Maas, Bart R.
Burgler, Myrthe M.
Kroeze, Yvet
Smink, Agnes
Bloem, Bastiaan R.
Munneke, Marten
Ben-Shlomo, Yoav
Darweesh, Sirwan K. L. http://orcid.org/0000-0002-4361-4593
Funding for this research was provided by:
Gatsby Charitable Foundation (GAT3676)
Article History
Received: 14 July 2023
Accepted: 25 March 2024
First Online: 30 May 2024
Declarations
:
: Dr. Sirwan Darweesh currently serves on the editorial board of Neurology, Frontiers of Neurology and Brain Sciences, has received fees for speaking at conferences and podcasts from AbbVie, and has received research support from the Parkinson's Foundation (PF-FBS-2026), ZonMW (09150162010183), ParkinsonNL (P2022-07 and P2021-14), Michael J Fox Foundation (MJFF-022767), Davis Phinney Foundation and Edmond J Safra Foundation (all paid to the institute). Prof. dr. Bastiaan R. Bloem currently serves as co-Editor in Chief for the Journal of Parkinson’s disease, serves on the editorial board of Practical Neurology and Digital Biomarkers, has received fees from serving on the scientific advisory board for the Critical Path Institute, Gyenno Science, MedRhythms, UCB, Kyowa Kirin and Zambon (paid to the institute), has received fees for speaking at conferences from AbbVie, Bial, Biogen, GE Healthcare, Oruen, Roche, UCB and Zambon (paid to the institute), and has received research support from Biogen, Cure Parkinson's, Davis Phinney Foundation, Edmond J. Safra Foundation, Gatsby Foundation, Hersenstichting Nederland, Horizon 2020, IRLAB Therapeutics, Maag Lever Darm Stichting, Michael J Fox Foundation, Ministry of Agriculture, Ministry of Economic Affairs & Climate Policy, Ministry of Health, Welfare and Sport, Netherlands Organization for Scientific Research (ZonMw), Not Impossible, Parkinson Vereniging, Parkinson's Foundation, Parkinson's UK, Stichting Alkemade-Keuls, Stichting Parkinson NL, Stichting Woelse Waard, Topsector Life Sciences and Health, UCB, Verily Life Sciences, Roche and Zambon. Prof. dr. Yoav Ben-Shlomo is a recipient of a Radboud Excellence award. He has received research support from the UK Medical Research Council, Wellcome Trust, NIHR, Parkinson’s UK, Versus Arthritis, Gatsby Foundation, and the Dunhill Trust. All other authors declare that they have no competing interests.
: The PRIME-NL study was exempted from further ethical approval after the study had been reviewed by the Ethical Board of the Radboudumc (file number 2019–5618).
: All questionnaire participants provided written or digital informed consent before study inclusion. As part of Dutch health insurance policy, all persons in the Vektis database agreed on using their data anonymously for scientific study purposes.
: As part of the informed consent, all participants agreed to the publication of scientific findings related to the study.